Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Exam (elaborations)

WGU D027 OBJECTIVE ASSESSMENT FINAL EXAM COMPLETE QUESTIONS AND CORRECT DETAILED ANSWERS WITH STUDY GUIDE AND ACTUAL EXAM ||ALREADY GRADED A +|| Latest Version

Rating
-
Sold
-
Pages
165
Grade
A+
Uploaded on
27-05-2025
Written in
2024/2025

WGU D027 OBJECTIVE ASSESSMENT FINAL EXAM COMPLETE QUESTIONS AND CORRECT DETAILED ANSWERS WITH STUDY GUIDE AND ACTUAL EXAM ||ALREADY GRADED A +|| Latest Version Autosomal Dominant - ANSWER 1 parent has, 50% change of child having Autosomal Recessive - ANSWER Both parents are carriers, 25% change of child having, 50% chance child is a carrier. Cystic Fibrosis - ANSWER affects pancreas causing secretions in lungs 21st Trisomy - ANSWER Down Syndrome Klinefelter Syndrome (XXY) - ANSWER male has extra X, female like qualities Turner Syndrome - ANSWER Missing X in females Alpha Thalassemia - ANSWER inherited blood disorder; mild to severe anemia Beta Thallasemia - ANSWER low hemoglobin; contraindicated medication ferrous sulfate Prevalence Risk - ANSWER proportion of the population affected at a certain time Incidence rate - ANSWER number of new cases divided by population Innate immunity - ANSWER inflammation; increased vascular permeability B&T lymphocytes - ANSWER immune response primary malignant tumor - ANSWER lack of organization of cells glucocorticoids - ANSWER used in combination with other agent to treat lymphoid tissue (leukemia). glucocorticoids are directly toxic to lymphoid tissues. Selective estrogen receptor modulators (SERM) - ANSWER for hormone receptor positive and advanced breast cancer. (Tamoxifin reduces risk and recurrence risk) Heart failure - ANSWER impairment of the ventricle to fill with or eject blood; heart cannot meet metabolic need of the body. CHF - ANSWER heart cannot keep up with metabolic needs; volume overload in pulmonary area Left Ventricular Dysfunction - ANSWER reduced ejection fraction; ventricle having issue ejecting blood. normal ejection fraction - ANSWER 55 - 60 % (blood pumped out with each heartbeat) Ejection fraction of 50% - reduced or preserved? - ANSWER preserved Diastolic CHF - ANSWER preserved ejection fraction, problem is with filling Systolic CHF - ANSWER reduced ejection fraction, problem is with ejecting Left sided CHF - ANSWER pulmonary (JVD, fluid volume overload, rails, S-3 murmurs) ** #1 cause of Right sided CHF BNP - ANSWER gold standard lab test to diagnose CHF Echocardiogram - ANSWER Diagnostic tool, evaluates heart structure and function At Risk for HF - Stage A - ANSWER no structural heart disease or symptoms of heart failure Stage A HF co-morbidities - ANSWER htn, atherosclerotic disease, diabetes, metabolic syndrome, patients using cardiotoxins with family history Therapy goals of stage A HF - ANSWER treat htn, encourage smoking cessation, encourage regular exercise, treat lipid disorders, discourage alcohol intake/drug use, control metabolic syndrome Meds: ACEI or Angiotensin II RB for vascular disease or diabetes (avapro, losartan, benicar, diovan, etc) At Risk for HF - Stage B - ANSWER structural heart disease but no symptoms of heart failure Stage B HF co-morbidities - ANSWER previous MI, LV remodeling with LV hypertrophy and low EF, asymptomatic valvular disease Therapy goals of Stage B HF - ANSWER Meds: ACEI or ARB, Beta-blockers, inplantable defibrillators Stage C heart failure - ANSWER structural heart disease with prior or current symptoms of HF Presentation of Stage C HF - ANSWER known structural heart disease and shortness of breath and fatigue, reduced exercise tolerance Therapy for Stage C HF - ANSWER dietary salt restriction, MEDS: diuretic, ACEI, beta blockers. Some patients: aldosterone antagonist, ARBs, digitalis, hydralazine/nitrates, biventricular pacing, inplantable defibrillators Stage D heart failure - ANSWER refractory HF requiring specialized interventions Presentation of Stage D HF - ANSWER marked symptoms at rest despite maximal medical therapy (recurrently hospitalized or cannot be safely discharged without specialized interventions) Therapy goals for Stage D HF - ANSWER compassionate end-of-life care/hospice, extraordinary measures ,heart transplant, chronic inotropes, permanent mechanical support, experimental drugs or surgery Ischemic heart Disease (CAD, MI) presentation - ANSWER chest discomfort, pain in neck/jaw/chest (crushing, squeezing, sharp), pain worse with exertion (demand requirement is higher), abnormal heart sounds, hypoxia, arrhythmias (afib, ST elevation) Stable angina goal - ANSWER decrease cardiac oxygen demand Meds for stable angina - ANSWER nitro first choice, then beta blockers (beta blockers if angina occurs with effort) nitroglycerine dose - ANSWER sublingual, acts within 5 minutes, max of 3 doses Cardiac glycosides (Digoxin) - ANSWER Increased myocardial contractile force (increases output), used in ED, exerts positive inotropic action, can cause severe dysrhythmias Digoxin Dosing - ANSWER therapeutic - 0.5-0.8 ng/ml. ASSESS apical pulse before administering, If lethargic and not acting right, see patient FIRST Goal of Anticoagulant and Antiplatelet Drugs - ANSWER inactivate and suppress formation of thrombin Warfarin (coumadin) - ANSWER PO to prevent blood clots; start with half a dose Anticoagulants - ANSWER Warfarin, heparin, lovenox; Caution about hemorrhage, any patients with risks for bleeding Pneumonia Patho - ANSWER pathogen reaches airway and overwhelms defenses causing inflammatory cascade; fluid forms, blocking diffusion (gas exchange) causing hypoxia, ultimately leads to respiratory failure Diagnosing pneumonia - ANSWER Chest X-ray: viral - diffuse widespread whitening; bacterial - patchy, consolidated, lobar Emphysema - ANSWER destruction of alveolar walls; air goes into lungs, can't get out; leads to hyperinflation Bronchitis - ANSWER excess mucus production, smooth muscle hypertrophy asthma - ANSWER chronic inflammatory obstruction of bronchi; trigger causing mucus clogging bronchial tubes; is reversable, give beta antagonists and steroids Foundation meds of asthma and COPD - ANSWER glucocorticosteroids: Pulmicort and Flovent; taken daily for long term control to suppress inflammation. Oral glucocorticoids - methylprednisone, prednisone; gradually decrease dose Bronchodilators (Beta 2-Adrenergic Agonists) - ANSWER provide symptomatic relief, do not effect inflammation of disease process; taken PRN during attack (Albuterol), long actinb Beta2 can be used in combo with glucocorticoids Back pain treatment - ANSWER first 4-6 weeks no imaging needed unless neurologic involved; give NSAIDS and rest, is the #1/2 reason for visits to PCP Types of Endocrine Disorders - ANSWER Diabetes Acromegaly - overproduction of growth hormone, have overbite and buffalo hump Addison's - decreased production of hormones by adrenal gland Cushing - high cortisol levels Graves - hyperthyroidism (excessive) Stage 1 Kidney Disease (CKD) - ANSWER kidney damage with normal or increased GFR, treat comorbid conditions to slow disease progression, CVD risk reduction Stage 2 CKD - ANSWER kidney damage with mild decreased GFR (60-89), Estimation of progression Stage 3 CKD - ANSWER moderate decreased GFR (30-59), treat complications Stage 4 CKD - ANSWER Severely decreased GFR (15-29), prepare for kidney replacement therapy Stage 5 CKD - ANSWER Kidney failure GFR 15 or dialysis, replacement if uremia present How do you start first dose of antihypertensives/heart failure medications? - ANSWER start first dose at night; do slow position changes, lay down if hypotension occurs Ace Inhibiters (ACEI) *pril - ANSWER reduce angiotensin II, increase bradykinin, hyperkalemia, dry cough, angioedema; contraindicated in pregnancy (fetal death), first dose causes severe hypotension, can cause renal failure Beta Blockers - ANSWER prevent chemical messengers; slow HR, relax vessels, lower BP, Class II antidysrhythmic drug nonselective beta blockers - ANSWER use with caution in people with lung conditions; do not use with asthma Cardio selective beta blockers - ANSWER metoprolol - only beta-1 receptors affected Third generation beta blockers - ANSWER labetalol - blocks alpha and beta receptors Calcium Channel Blockers - ANSWER vasodilation of arterioles and heart, class IV antidysrhythmic drug Verapamil - ANSWER calcium channel blocker, first choice dihydropyridines CCB - ANSWER *ine, vasodilators used to treat htn and angina non-dihydropyridines CCB - ANSWER *dilt, used for arrhythmias Statins - ANSWER lipid lowering agents (LDL), can increase good HDL, muscle pain can lead to rhabdo, kidney failure, and death Diuretics - ANSWER 2 hours after oral intake, peaks at 4-6 hours, lasts 12 hours Thiazide Diuretics - ANSWER block reabsorption (10%) in distal convoluted tubule; not used in kidney failure, can cause hypokalemia, not used in sickle cell disease Loop diuretics - ANSWER Furosemide; blocks reabsorption (20%) in loop of Henle Potassium-sparing diuretics - ANSWER Spironolactone (Aldactone); distal nephron, holds K, excretes sodium, takes 48 hours to work Angiotensin II - ANSWER vasocontraction; increased bp by acting on adrenal cortex secreting aldosterone Antiotensin II Receptor Blockers (ARBS) - ANSWER Sartan; blocks action of angiotensin II, second choice if cannot tolerate ACE for htn and HF Diabetes diagnosis - ANSWER Hgb A1C is most reliable assessment of blood glucose over 3 month period. Poor control is 9%, goal is 6.5% in healthy people Short acting insulin - ANSWER lispro (Humalog)/Aspart (NovoLog)/glulisine (aspirdra) Long acting insulin - ANSWER glargine (Lantus) - most painful; detemir (levemir) Metformin - ANSWER first drug of choice with new Type 2 Diabetes; inhibits glucose in liver, slightly reduces glycose absorption in gut, increases glucose uptake; DOES NOT drive insulin down, very low risk for hypoglycemia TSH levels - ANSWER normal range is 0.4 to 4.0 mu/L. If you are being treated for a thyroid disorder, the normal range is 0.5 to 3.0 mu/L. A value above the normal range indicates that the thyroid is underactive. This indicates hypothyroidism. Hypothyroidism Presentation - ANSWER inadequate amounts of hormone; slows body function and processes, cold, pale puffy face, skin cool and dry, low HR, low temp, lethargy, fatigue Hypothyroidism in pregnancy - ANSWER must be treated to prevent a child's neurological problems Hypothyroidism in newborns - ANSWER require replacement within a few days, lasts for 3 years, prevents mental development changes and growth patters, dwarfish How do you take Levothyroxine (t4) - ANSWER on an empty stomach for increased absorption Hashimoto disease presentation - ANSWER weight gain and fatigue; autoimmune disease Hyperthyroidism (thyrotoxicosis) presentation - ANSWER elevations in T4 and T3, tachyarrhythmias, anxiety, insomnia, rapid speech, hot Graves Disease - ANSWER women 20-40 most susceptible, remove or destroy thyroid tissue or suppress with drugs (methimazole or propylthiouracil), treat with Iodine - I31, beta blockers also used to suppress release of thyroid hormones Plummer disease (toxic nodular goiter) - ANSWER result of thyroid adenoma (tumor), same as Graves disease, but absence of exophthalmos (bulging eyes) Thyroid storm - ANSWER caused by major surgery or severe illness such as sepsis, 105 F, severe tachycardia, restlessness, tremor, heart failure, coma. Treat with Propylthiouracil (PTU), symptom management Histamine - 1 antihistamines - ANSWER cause vasodilation, bronchoconstriction, help with memory and sleep. Relieve itching, pain, secretion, and mucus (allergies). Side effects: sedative, dry mouth, urinary hesitancy,, constipation. Second generation (-ine) are non-sedating Histamine 2 Receptor Antagonists - ANSWER secretion of gastric acid; treat gastric and duodenal ulcers Stage I HTN - ANSWER 130-139/80-89 Stage 2 HTN - ANSWER 140/90 Med used after heart attack - ANSWER Beta blocker - use for 6 months Meds for ischemic vascular disease - ANSWER aspirin or antithrombotic Cervical cancer screening - ANSWER 21 - 64 cytology every 3 years, 30-64 cytology and HPV every 5 years Pneumonia CURB - ANSWER Confusion, Urea 7, RR 30, BP 90 or 60, Age 65 0-1 = home treatment, 2 = short stay hospital, 3+ = severe pneumonia (ICU) End of Life care - ANSWER optimize patient's comfort and function while avoiding unnecessary side effects First line of depression treatment - ANSWER SSRIs - low side effects with good effectiveness Stress - ANSWER exacerbates many serious health issues, stress cannot cause cancer broken heart syndrome - ANSWER mimics MI, no coronary obstruction SDOH - ANSWER social determinants of health Types of SDOHs - ANSWER access to healthy foods, health literacy, housing stability, socioeconomic status, rural vs. urban healthcare access Amoxicillin - ANSWER first line of treatment for uncomplicated otitis media in pediatric patient without comorbidities POTS - ANSWER Postural Orthostatic Tachycardia Syndrome Treatment of POTS - ANSWER stand slowly, lay back down if needed, add extra salt increase fluids, MEDS: Florinef Symptoms/Diagnosing POTS - ANSWER Tilt Test - HR increases by 30 bpm when standing up or over 120 in first 10 minutes, symptoms are related to reduced blood volume when standing up, can cause lightheadedness, fainting Florinef - ANSWER Used to treat conditions which glucocorticoids are low. These conditions include Addison's disease, adrenocortical insufficiency. *Also treats orthostatic hypotension; Side effects: nausea, headache, sleep problems, mood changes Off label use for prazosin/minipress - ANSWER sleep aid for patients diagnosed with PTSD Myasthenia Gravis - ANSWER a neuromuscular disorder characterized by muscle weakness and rapid fatigue, drooping eyelids, difficulty swallowing, generalized weakness Meds used to treat myasthenia gravis - ANSWER corticosteroids - treat diplopia and suppress adrenal function; take 4-6 weeks then taper Cholinesterase inhibitors - neostigmine Side effects of cholinesterase inhibitors - ANSWER excessive salivation, urinary incontinence/urgency, sweating, muscle spasm, bradycardia Med: neostigmine therapeutic levels produce mild stimulation Toxic levels depress CNS (BBB) - treat with respiratory support and atropine thyrotoxicosis - ANSWER condition caused by the exposure of body tissue to excessive levels of thyroid hormone first line treatment for uncomplicated HTN - ANSWER hydrochlorothiazide, oral with lifestyle changes Ataxia in pediatric patient - ANSWER genetic predisposition, Fragile X syndrome, Prader-Willie Syndrome Prader-Willie Syndrome - ANSWER deletion of chromosome from father

Show more Read less
Institution
Course

Content preview

WGU D027 OBJECTIVE
ASSESSMENT FINAL EXAM
COMPLETE QUESTIONS AND
CORRECT DETAILED ANSWERS
WITH STUDY GUIDE AND ACTUAL
EXAM ||ALREADY GRADED A +||
Latest Version 2025-2026

Autosomal Dominant - ANSWER 1 parent has, 50% change of child
having

Autosomal Recessive - ANSWER Both parents are carriers, 25% change
of child having, 50% chance child is a carrier.

Cystic Fibrosis - ANSWER affects pancreas causing secretions in lungs

21st Trisomy - ANSWER Down Syndrome

Klinefelter Syndrome (XXY) - ANSWER male has extra X, female like
qualities

Turner Syndrome - ANSWER Missing X in females

Alpha Thalassemia - ANSWER inherited blood disorder; mild to severe
anemia

Beta Thallasemia - ANSWER low hemoglobin; contraindicated
medication ferrous sulfate

Prevalence Risk - ANSWER proportion of the population affected at a
certain time

Incidence rate - ANSWER number of new cases divided by population

,Innate immunity - ANSWER inflammation; increased vascular
permeability

B&T lymphocytes - ANSWER immune response

primary malignant tumor - ANSWER lack of organization of cells

glucocorticoids - ANSWER used in combination with other agent to treat
lymphoid tissue (leukemia). glucocorticoids are directly toxic to
lymphoid tissues.

Selective estrogen receptor modulators (SERM) - ANSWER for
hormone receptor positive and advanced breast cancer. (Tamoxifin
reduces risk and recurrence risk)

Heart failure - ANSWER impairment of the ventricle to fill with or eject
blood; heart cannot meet metabolic need of the body.

CHF - ANSWER heart cannot keep up with metabolic needs; volume
overload in pulmonary area

Left Ventricular Dysfunction - ANSWER reduced ejection fraction;
ventricle having issue ejecting blood.

normal ejection fraction - ANSWER 55 - 60 % (blood pumped out with
each heartbeat)

Ejection fraction of 50% - reduced or preserved? - ANSWER preserved

Diastolic CHF - ANSWER preserved ejection fraction, problem is with
filling

Systolic CHF - ANSWER reduced ejection fraction, problem is with
ejecting

Left sided CHF - ANSWER pulmonary (JVD, fluid volume overload,
rails, S-3 murmurs) ** #1 cause of Right sided CHF

BNP - ANSWER gold standard lab test to diagnose CHF

Echocardiogram - ANSWER Diagnostic tool, evaluates heart structure
and function

, At Risk for HF - Stage A - ANSWER no structural heart disease or
symptoms of heart failure

Stage A HF co-morbidities - ANSWER htn, atherosclerotic disease,
diabetes, metabolic syndrome, patients using cardiotoxins with family
history

Therapy goals of stage A HF - ANSWER treat htn, encourage smoking
cessation, encourage regular exercise, treat lipid disorders, discourage
alcohol intake/drug use, control metabolic syndrome
Meds: ACEI or Angiotensin II RB for vascular disease or diabetes
(avapro, losartan, benicar, diovan, etc)

At Risk for HF - Stage B - ANSWER structural heart disease but no
symptoms of heart failure

Stage B HF co-morbidities - ANSWER previous MI, LV remodeling
with LV hypertrophy and low EF, asymptomatic valvular disease

Therapy goals of Stage B HF - ANSWER Meds: ACEI or ARB, Beta-
blockers, inplantable defibrillators

Stage C heart failure - ANSWER structural heart disease with prior or
current symptoms of HF

Presentation of Stage C HF - ANSWER known structural heart disease
and shortness of breath and fatigue, reduced exercise tolerance

Therapy for Stage C HF - ANSWER dietary salt restriction, MEDS:
diuretic, ACEI, beta blockers. Some patients: aldosterone antagonist,
ARBs, digitalis, hydralazine/nitrates, biventricular pacing, inplantable
defibrillators

Stage D heart failure - ANSWER refractory HF requiring specialized
interventions

Presentation of Stage D HF - ANSWER marked symptoms at rest despite
maximal medical therapy (recurrently hospitalized or cannot be safely
discharged without specialized interventions)

Therapy goals for Stage D HF - ANSWER compassionate end-of-life
care/hospice, extraordinary measures ,heart transplant, chronic inotropes,
permanent mechanical support, experimental drugs or surgery

, Ischemic heart Disease (CAD, MI) presentation - ANSWER chest
discomfort, pain in neck/jaw/chest (crushing, squeezing, sharp), pain
worse with exertion (demand requirement is higher), abnormal heart
sounds, hypoxia, arrhythmias (afib, ST elevation)

Stable angina goal - ANSWER decrease cardiac oxygen demand

Meds for stable angina - ANSWER nitro first choice, then beta blockers
(beta blockers if angina occurs with effort)

nitroglycerine dose - ANSWER sublingual, acts within 5 minutes, max
of 3 doses

Cardiac glycosides (Digoxin) - ANSWER Increased myocardial
contractile force (increases output), used in ED, exerts positive inotropic
action, can cause severe dysrhythmias

Digoxin Dosing - ANSWER therapeutic - 0.5-0.8 ng/ml. ASSESS apical
pulse before administering, If lethargic and not acting right, see patient
FIRST

Goal of Anticoagulant and Antiplatelet Drugs - ANSWER inactivate and
suppress formation of thrombin

Warfarin (coumadin) - ANSWER PO to prevent blood clots; start with
half a dose

Anticoagulants - ANSWER Warfarin, heparin, lovenox; Caution about
hemorrhage, any patients with risks for bleeding

Pneumonia Patho - ANSWER pathogen reaches airway and overwhelms
defenses causing inflammatory cascade; fluid forms, blocking diffusion
(gas exchange) causing hypoxia, ultimately leads to respiratory failure

Diagnosing pneumonia - ANSWER Chest X-ray: viral - diffuse
widespread whitening; bacterial - patchy, consolidated, lobar

Emphysema - ANSWER destruction of alveolar walls; air goes into
lungs, can't get out; leads to hyperinflation

Bronchitis - ANSWER excess mucus production, smooth muscle
hypertrophy

Written for

Course

Document information

Uploaded on
May 27, 2025
Number of pages
165
Written in
2024/2025
Type
Exam (elaborations)
Contains
Questions & answers

Subjects

$14.09
Get access to the full document:

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Get to know the seller

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
DocPatricia Teachme2-tutor
Follow You need to be logged in order to follow users or courses
Sold
11
Member since
1 year
Number of followers
0
Documents
191
Last sold
6 days ago
DOCPATRICIA STUDY HUB

**Need Help with Assignments, Test Banks, Essays, or Tutoring?** I offer high-quality academic assistance across a wide range of subjects and complexity levels. With a strong commitment to punctuality, I ensure all work is delivered on time and meets academic standards. Whether it’s research papers, case studies, psychology assignments, or other topics, I put my best effort into every project. Academic writing is a passion of mine—I take pride in crafting well-structured, engaging, and informative content tailored to your requirements. I’m dedicated to producing original work that follows proper formatting and exceeds expectations. **Refer a friend!** For every successful referral (completed and paid order), you’ll receive one free assignment as a thank-you. Let me take your assignments to the next level—send your instructions and I’ll handle the rest with fresh insights, clarity, and precision.

Read more Read less
3.8

4 reviews

5
1
4
1
3
2
2
0
1
0

Recently viewed by you

Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions